enGene is focused on developing non-viral genetic medicines, particularly for treating non-muscle invasive bladder cancer (NMIBC) through its investigational therapy, Detalimogene
enGene is focused on developing non-viral genetic medicines, particularly for treating non-muscle invasive bladder cancer (NMIBC) through its investigational therapy, Detalimogene.